Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × Bortezomib × Clear all

NCT00458913 2018-07-12

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00513877 2014-12-31

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant